Viewing Study NCT06451718



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06451718
Status: RECRUITING
Last Update Posted: 2024-06-11
First Post: 2024-05-07

Brief Title: First in Human Study to Assess the Safety and the Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus
Sponsor: Fundacio De Recerca Del Instituto De Microcirugia Ocular
Organization: Fundacio De Recerca Del Instituto De Microcirugia Ocular

Study Overview

Official Title: First in Human Study to Assess the Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Stage 3 and 4 Keratoconus KC
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This Study is a first in human clinical study addressed to evaluate the safety and efficacy of a novel intra-corneal nitinol device Investigational Device GROSSO implant for the treatment of advanced keratoconus disease of the eye
Detailed Description: The medical device under investigation is a sterile thin 8-mm diameter circular scaffold made of a nickel-titanium alloy nitinol that is intended as a permanent implant that is surgically inserted into the cornea in order to modify force by inducing a change in corneal shape and consequently improving vision This Study is aimed at adults with a stage 3-4 keratoconus a central K reading 5300 D and RMS of coma aberration 35 which are not eligible for Intrastromal Corneal Ring Segments ICRS and are recommended for keratoplasty

Therefore this study represents a salvage route to preserve the cornea Envisaged worst case scenario of failure of the experimental device patients would be redirected to keratoplasty

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None